These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16218319)

  • 1. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
    Musana AK; Wilke RA
    WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antipsychotics: useful for the clinician?
    Bondy B; Spellmann I
    Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
    Saggar S; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
    Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
    Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphisms in drug-metabolizing enzymes].
    Saruwatari J; Nakagawa K; Ishizaki T
    Nihon Rinsho; 2002 Jan; 60(1):58-63. PubMed ID: 11808340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].
    Yamazoe Y; Nagata K
    Nihon Rinsho; 2001 Aug; 59(8):1614-23. PubMed ID: 11519169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between drug-induced interstitial lung diseases and cytochrome P450 polymorphisms.
    Wijnen PA; Bekers O; Drent M
    Curr Opin Pulm Med; 2010 Sep; 16(5):496-502. PubMed ID: 20592596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial pharmacogenetics.
    Wilke RA; Reif DM; Moore JH
    Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacogenetics/pharmacogenomics in psychiatry].
    Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
    Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for pharmacogenetics and its clinical application in drug therapy.
    Hiratsuka M; Sasaki T; Mizugaki M
    Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.